SJ

Shah Jigneshkumar Ashwin

Active Director Managing Director DIN 03113210
DIN 03113210 First appointment Jul 2011 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Jul 2011
Shareholding value •••• Premium profile

About Shah Jigneshkumar Ashwin

Data last updated:

Shah Jigneshkumar Ashwin is a Managing Director at Asons Pharmaceuticals Private Limited (since 2021), Whole-Time Director at Purecaps India Private Limited (since 2021) and Director at Asons Biotech Private Limited (since 2023). The companies operate in Pharma, Agriculture and Consumer Goods. The 2 current companies with reported revenue have a combined latest revenue of ₹32.73 Cr; the largest is Asons Pharmaceuticals Private Limited at ₹32.40 Cr (FY 2025). Earlier, Shah Jigneshkumar Ashwin was a Director at Universal Skin Impex Private Limited (2011–2018) and Additional Director at Astral Steritech Private Limited (from 2025).

DIN 03113210
Primary Designation Managing Director
Industry Pharma
First Appointment 28 Jul 2011
Oldest Company Age 14 yrs
Largest company Asons Pharmaceuticals Private Limited · ₹32.40 Cr (FY 2025)
Combined revenue ₹32.73 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director02 Sep 20212021₹32.40 Cr (FY 2025)Active
Purecaps India Private Limited U24239GJ2021PTC125836
Whole-Time Director24 Sep 20212021₹33.3 Lakh (FY 2025)Active
Asons Biotech Private Limited U47737GJ2023PTC140648
Director28 Apr 20232023Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Universal Skin Impex Private Limited U52190GJ2011PTC066565
Director28 Jul 20112011₹1.38 Cr (FY 2022)Active
Astral Steritech Private Limited U24100GJ2012PTC071810
Additional Director09 Jun 20252012₹202 Cr (FY 2022)Under Cirp

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Asons Pharmaceuticals Private Limited
Purecaps India Private Limited
Astral Steritech Private Limited
Asons Biotech Private Limited
Premium access

Shareholding and investment profile for Shah Jigneshkumar Ashwin

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shah Jigneshkumar Ashwin

Shah Jigneshkumar Ashwin currently holds 3 directorships: Asons Pharmaceuticals Private Limited (Managing Director, since 02 Sep 2021, revenue ₹32.40 Cr (FY 2025)); Purecaps India Private Limited (Whole-Time Director, since 24 Sep 2021, revenue ₹33.3 Lakh (FY 2025)); Asons Biotech Private Limited (Director, since 28 Apr 2023).

Shah Jigneshkumar Ashwin was first appointed on 28 Jul 2011 as Director at Universal Skin Impex Private Limited. The most recent appointment on record is 09 Jun 2025 at Astral Steritech Private Limited.

The 2 current companies of Shah Jigneshkumar Ashwin that report revenue have a combined latest revenue of ₹32.73 Cr: Asons Pharmaceuticals Private Limited ₹32.40 Cr (FY 2025); Purecaps India Private Limited ₹33.3 Lakh (FY 2025).

Shah Jigneshkumar Ashwin held 2 earlier board appointments: Universal Skin Impex Private Limited (Director, 28 Jul 2011 to 04 Apr 2018); Astral Steritech Private Limited (Additional Director, from 09 Jun 2025).

The current boards of Shah Jigneshkumar Ashwin's companies include Devangiben Jigneshkumar Shah (Asons Pharmaceuticals Private Limited), Kiran Mohanlal Jain (Asons Pharmaceuticals Private Limited), Uttamkumar Mohanlal Jain (Asons Pharmaceuticals Private Limited), Ronit Kirankumar Jain (Purecaps India Private Limited), Samkitkumar Jain (Purecaps India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available